Search

Displaying results 2161 - 2170 of 9697 in total
  1. Drug

    Matsupexole

    go.drugbank.com/drugs/DB21715
    Experimental

    Matsupexole is a small molecule drug. Matsupexole has a monoisotopic molecular weight of 446.25 Da.

  2. Drug

    Balinatunfib

    go.drugbank.com/drugs/DB21728
    Investigational

    Balinatunfib is a small molecule drug. Balinatunfib has a monoisotopic molecular weight of 502.19 Da.

  3. Drug

    Rogocekib

    go.drugbank.com/drugs/DB21739
    Investigational

    Rogocekib is a small molecule drug. Rogocekib has a monoisotopic molecular weight of 408.15 Da.

  4. Drug

    Caldaret

    go.drugbank.com/drugs/DB06231
    Investigational

  5. Drug

    PXT 3003

    go.drugbank.com/drugs/DB16745
    Investigational

    PXT 3003 is in phase 3 clinical trials for the treatment of Charcot-Marie-Tooth disease type 1A in adults.

  6. Drug

    LP-2307

    go.drugbank.com/drugs/DB17470
    Experimental

    LP-2307 is an investigational allogeneic large multivalent immunogen (LMI) vaccine developed by Avanir. It was investigated for melanoma.

    Synonyms: LP 2307
  7. Drug

    LY-2623091

    go.drugbank.com/drugs/DB15367
    Investigational

    LY-2623091 is under investigation in clinical trial NCT02194465 (A Study of LY2623091 in Participants With High Blood Pressure).

  8. Drug

    Iomethin I-131

    go.drugbank.com/drugs/DB21079
    Experimental

    Iomethin I-131 is a small molecule drug. Iomethin I-131 has a monoisotopic molecular weight of 359.06 Da.

  9. Drug

    Benmelstobart

    go.drugbank.com/drugs/DB17473
    Investigational

    APL 502 is a humanised immunoglobulin G1 (IgG1) monoclonal antibody targeting the programmed cell death-1 ligand-1 (PD-L1).

  10. Drug

    DTx-1252

    go.drugbank.com/drugs/DB18086
    Experimental

    DTx-1252 is a siRNA therapeutic under investigation for the treatment of Charcot-Marie-Tooth Disease type 1A (CMTD1A).[L48096]